11th Edition of International Conference on
Neurology and Neurological Disorders
June 05-07, 2025 | Rome, Italy
Neuropharmacology and Novel Drug Development
Neuropharmacology and novel drug development are at the forefront of tackling neurological and psychiatric disorders. This field focuses on understanding the interactions between drugs and the nervous system to design targeted therapies. Advances in receptor biology, neurotransmitter dynamics, and signal transduction pathways are driving innovations in drug discovery. Emerging technologies, such as high-throughput screening and in silico modeling, accelerate the identification of potential therapeutic compounds. Breakthroughs in neuropharmacology also emphasize precision medicine, tailoring treatments to individual genetic and biochemical profiles. These developments hold promise for addressing challenges in managing disorders like schizophrenia, epilepsy, and neurodegeneration effectively.
Ken Ware
NeuroPhysics Therapy Institute, Australia
Robert B Slocum
University of Kentucky HealthCare, United States
Luiz Moutinho
University of Suffolk, United Kingdom
David Lominadze
University of South Florida, United States
Dixie J Woolston
Mayo Clinic Arizona/Scottsdale, United States
David Sperbeck
Private Practice, United States
Sang Hie Lee
University of South Florida, United StatesSubmit your abstract Today
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : ACE-dependent alzheimer’s disease
Sergei M Danilov, University of Illinois, United States
Title : Essential roles, mechanisms and consequences of vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Narrative medicine: A communication therapy for the communication disorder of Psychogenic Non-Epileptic Seizures (PNES) also known as Functional Seizures (FS)
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Who cares …… for the carers
Jaqueline Tuppen, COGS Club, United Kingdom
Title : Parkinson's disease, aging and mitochondria
Ming Guo, UCLA David Geffen School of Medicine, United States